FDA approves Abilify for treating autistic irritability - Related Stories - AAP SmartBrief

Links shared publicly online about this topic.

1,580
total visits

FDA approves Abilify for treating autistic irritability - Related Stories - AAP SmartBrief

The FDA approved Abilify for treating irritability in autistic children ages 6 to 17 years. Bristol-Myers Squibb said approval was based on data from two Phase III studies that showed Abilify, when compared with a placebo, significantly improved scores on the Irritability subscale of the Aberrant Be

View full resource at smartbrief.com

Tags: Bipolar Disorder Medication, Autism Spectrum Disorder, Autism, Schizophrenia Medication, Antipsychotic Medication, FDA, Abilify